eclitasertib (DNL758) / Harvard University, Sanofi, Denali Therap 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eclitasertib (DNL758) / Denali Therap, Sanofi
CLEan, NCT04781816 / 2020-004703-14: Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

Completed
2
78
Europe, Canada, US, RoW
SAR443122, Placebo
Sanofi
Cutaneous Lupus Erythematosus
05/23
06/23
RESOLUTE, NCT05588843: Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

Recruiting
2
182
Europe, Japan, US, RoW
SAR443122, Placebo
Sanofi
Colitis Ulcerative
11/25
09/26

Download Options